What is BASi?
BASi, operating through its Northwest Laboratory and Northwest Pathology divisions, serves as a critical node in the diagnostic healthcare ecosystem. The company provides a comprehensive suite of services, including histology, immunohistochemistry, hematology, and molecular testing, supported by a robust laboratory information system. With a reach extending to 37 states and partnerships with over 100 outpatient clinics and 13 hospitals, the firm functions as a high-volume, precision-oriented diagnostic partner. Its integration with NW Pathology allows for seamless physician consultation, bridging the gap between raw laboratory data and actionable clinical insights for medical organizations across Washington, Alaska, and beyond.
How much funding has BASi raised?
BASi has raised a total of $15.2M across 3 funding rounds:
Stock Offering
$10M
Debt
$5M
Debt
$150K
Stock Issuance/Offering (1997): $10M, investors not publicly disclosed
Debt (2020): $5M led by PPP
Debt (2024): $150K supported by BayFirst National Bank
Key Investors in BASi
BayFirst National Bank
A community-focused financial institution providing commercial banking solutions and strategic debt financing to support business expansion.
PPP
Public-Private Partnership
Undisclosed Investor
An institutional participant providing capital to support long-term corporate development and strategic initiatives.
What's next for BASi?
With the recent influx of capital, BASi is well-positioned to accelerate its enterprise-level growth strategy. The focus will likely shift toward enhancing its digital health infrastructure, specifically optimizing the direct interfacing of its laboratory information system with electronic medical records. Furthermore, the company is expected to deepen its investment in specialized molecular testing and women's health diagnostics, areas that represent significant growth vectors in modern pathology. By maintaining its rigorous standards for specimen handling and expanding its courier logistics, BASi aims to solidify its status as a premier national reference laboratory, driving efficiency and clinical excellence in an increasingly complex healthcare market.
See full BASi company page
